Health
Novavax coronavirus vaccine shown to be 89 per cent effective in UK trial – SBS News
A mid-stage trial of the vaccine in South Africa, where a new variant of the virus is common, showed 60 per cent effectiveness among people who did not have HIV….
Novavax Inc said on Thursday its vaccine was 89.3 per cent effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious variant first discovered there, according to a preliminary analysis.
A mid-stage trial of the vaccine in South Africa, where a troubling new variant of the virus is common, showed 60 per cent effectiveness among people who did not have HIV.
Novavax shares surged 34 per cent in after hours…
-
General23 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General22 hours agoJaguar Land Rover in UK pauses shipments to US
-
General20 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General18 hours agoAustralian share market set to dive as threat of US recession grows